Mark D Stegall1, Suresh Raghavaiah, James M Gloor. 1. Division of Transplantation Surgery, Department of Surgery, von Liebig Transplant Center, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. stegall.mark@mayo.edu
Abstract
PURPOSE OF REVIEW: To outline recent advances in our understanding of the role of B cells in transplantation. RECENT FINDINGS: While T-cell-mediated alloimmunity has been largely controlled using immunosuppression, the role of B cells in transplantation is just beginning to be understood. Recent studies have outlined some of the important clinical issues involving antibody including early acute humoral rejection and late transplant glomerulopathy. In addition, recent studies have identified bone-marrow-derived long-lived plasma cells that appear to be a major source of donor-specific alloantibody in sensitized renal transplant recipients. New agents are being tested that deplete these cells in vitro and in vivo. Memory B cells appear to be important in early acute humoral rejection, but few basic studies have been performed. Finally, recent studies involving patients undergoing tolerogenic regimens suggest that T-cell tolerance does not always convey tolerance in naive B cells. SUMMARY: Several B cell types have clear and specific roles in transplant recipients. Although our understanding of B cells in transplantation has improved, important gaps remain.
PURPOSE OF REVIEW: To outline recent advances in our understanding of the role of B cells in transplantation. RECENT FINDINGS: While T-cell-mediated alloimmunity has been largely controlled using immunosuppression, the role of B cells in transplantation is just beginning to be understood. Recent studies have outlined some of the important clinical issues involving antibody including early acute humoral rejection and late transplant glomerulopathy. In addition, recent studies have identified bone-marrow-derived long-lived plasma cells that appear to be a major source of donor-specific alloantibody in sensitized renal transplant recipients. New agents are being tested that deplete these cells in vitro and in vivo. Memory B cells appear to be important in early acute humoral rejection, but few basic studies have been performed. Finally, recent studies involving patients undergoing tolerogenic regimens suggest that T-cell tolerance does not always convey tolerance in naive B cells. SUMMARY: Several B cell types have clear and specific roles in transplant recipients. Although our understanding of B cells in transplantation has improved, important gaps remain.
Authors: Gerhard Opelz; Kenneth G C Smith; Menna R Clatworthy; Rebeccah J Matthews; Bernd Doehler; Lisa C Willcocks Journal: Transplantation Date: 2014-08-15 Impact factor: 4.939
Authors: Sherri Wood; Jiane Feng; Jooho Chung; Vedran Radojcic; Ashley R Sandy-Sloat; Ann Friedman; Amy Shelton; Minhong Yan; Christian W Siebel; D Keith Bishop; Ivan Maillard Journal: J Immunol Date: 2015-02-16 Impact factor: 5.422
Authors: Ramiro Fernandez; Stephen Chiu; Kirtee Raparia; Puneet Garcha; Carol Farver; Marie Budev; Anat R Tambur; Malcolm M DeCamp; Scott Budinger; Harris Perlman; T Mohanakumar; Ankit Bharat Journal: Ann Thorac Surg Date: 2016-10 Impact factor: 4.330
Authors: Xiaojie Wang; Jianqiang Hao; Daniel L Metzger; Alice Mui; I-Fang Lee; Noushin Akhoundsadegh; C Lieping Chen; Dawei Ou; Ziliang Ao; C Bruce Verchere; Garth L Warnock Journal: Islets Date: 2012-07-01 Impact factor: 2.694